- Open Access
Supernormal Electro-Oculograms in Patients with Neurofibromatosis Type 1
Hereditary Cancer in Clinical Practice volume 2, Article number: 193 (2004)
To asses the retinal pigment epithelium (RPE) function measured by EOG testing in patients with neurofibromatosis type 1 (NF-1). Our preliminary EOG results suggested dysfunction of the RPE in individuals with NF-1. In order to confirm our initial results we performed EOG examination on a larger group of NF-1 patients.
Studies were performed on 36 patients with clinically diagnosed NF-1 and compared to normal healthy controls.
Standard EOG recordings were performed in accordance with the International Society for Clinical Electrophysiology of Vision (ISCEV) standards.
In NF-1 patients the Arden indexes of the EOG test were significantly higher primarily due to the lower values of dark troughs. Supernormal EOGs (exceeding the value of the mean + 2 SD from the control group) were present in 58% of NF-1 patients.
Dysfunction of the RPE is a characteristic feature of individuals with NF-1.
Neurofibromatosis type 1 (NF-1), or von Recklinghausen disease is one of the most common genetic multisystem progressive disorders with an incidence of approximately 1:3000 live births. In the eye, the disorder is characterised by Lisch nodules, optic gliomas, choroidal hamartomas and congenital hypertrophy of the retinal pigment epithelium (CHRPE) [1, 2]. The gene for NF-1 is localized to chromosome 17q11.2. and its protein product has been termed neurofibromin [3, 4]. It appears that reduction of neurofibromin expression can lead to abnormalities in the differentiation and migration of melanoblasts and melanocytes which gives rise to characteristic café-au-lait spots of the skin . Café-au-lait spots are characterised by increased levels of epidermal melanogenesis  and increased numbers of epidermal melanocytes  which contain abnormally large pigment granules, known as macromelanosomes. In the eye, Lisch nodules consist of masses of melanocytes. The choroidal hamartoma is similar to the iris lesion histopathologically. Congenital hypertrophy of retinal pigment epithelium, a rare feature of patients with NF-1, consists of focal areas of pigment epithelial cells that are more densely packed with pigmented granules .
Retinal pigment epithelium (RPE) also contains melanin. It can be hypothesized that changes in neurofibromin expression are leading to some melanin changes also in RPE of patients with NF-1. It has been described in patients with albinism that the reduced level or absence of retinal pigment is associated with changes detectable by EOG  - the most commonly used electrophysiological test of RPE function [10, 11].
Our initial EOG  results suggested that dysfunction of the RPE may be a characteristic feature of individuals with NF-1. In order to verify our preliminary findings we performed the EOG examination in a two-fold larger group of patients diagnosed with NF-1.
Materials and methods
The EOGs were performed on 36 patients (67 eyes; 22 males, 14 females; mean age: 26.6 ± 10.9 years; mean refractive error: -0.21 ± 0.72 D) who fulfilled the National Institutes of Health clinical diagnostic criteria for NF-1 [7, 13] and compared to 32 healthy subjects. Ocular findings in a group of patients with NF-1 are as follows: Snellen visual acuity - 20/20, Lisch nodules - (65/67) 97% of analysed eyes, choroidal hamartoma - (5/67) 7.4%, CHRPE (congenital hypertrophy of the retinal pigment epithelium) - (4/67) 5.9%, optic nerve glioma - (3/67) 4.4%, normal colour vision and visual field measured by kinetic perimetry. The two groups were similar as far as age, sex and refractive error were concerned. Uncooperative patients were excluded from the study.
Electro-oculography (UTAS E-2000) was performed according to the Standard for EOGs of the International Society for Clinical Electrophysiology of Vision (ISCEV) Standardisation Committee [10, 11]. In the EOG examination, patients' pupils were dilated (10% neo-synephrine, 1% tropicamide) and a stimulus intensity equal to ca. 100 cd· m-2 (aperture 1/2) was used, which has been recommended as a standard for the light adaptation phase in this case. We analysed the values of the lowest potential reached during the dark phase (dark-trough amplitude in μV, DTA), dark-trough latency (DTL) measured in minutes, the highest potential reached during light exposure (light-peak amplitude in μV, LPA), light-peak latency (LPL) in minutes and the ratio of the light-peak amplitude to dark-trough amplitude (Arden Index, AI).
Statistical analysis was performed using parametric (Shapiro-Wilk test, Student t-test) and non-parametric (Mann-Whitney test) tests with a significance level of p ≤ 0.05. This study was approved by the Committee of Medical Ethics of the Medical University in Szczecin.
Descriptive statistics and statistical analysis of the EOG parameters for two study groups (NF-1 patients and normal controls) are shown in Table 1. The Student t-test and the Mann-Whitney test revealed significant differences in the variables DTA (p < 0.001), AI (p < 0.001), and LPL (p < 0.001). Figure 1 illustrates an example of an NF-1 patient with supernormal AI on EOG examination.
For the NF-1 group, the mean DTA (305.0 ± 81.2 μV) was significantly lower than that of the control group (408.1 ± 112.9 μV) and the mean AI (3.42 ± 0.62) was significantly higher (2.45 ± 0.37). The mean LPL for the NF-1 group (7.6 ± 1.1 min) was significantly lower than that of the control group (8.4 ± 1.3 min). The mean LPA of the NF-1 group (971 ± 229 μV) was lower than that of the normal subjects (982 ± 242 μV); this difference was not statistically significant. The mean DTL for the NF-1 group (11.6 ± 2.2 min) was almost the same as that of the control group (11.7 ± 2.0 min).
In the group of patients with NF-1 we found no subnormal EOGs. Supernormal EOGs (AI>mean+2SD - more than 3.19) were detected in 58.3% (21/36) of patients, 58.2% (34/67) of eyes.
The results of our studies suggest that dysfunction of RPE as measured by EOG is present in patients with NF-1. Enlargement of the analysed eyes of patients with NF-1 (from 35 to 67 eyes) did not change significantly the EOG results obtained in a group of patients with NF-1 published previously . We observed a supernormal EOG (increased AIs) in 58% of analyzed eyes in individuals with NF-1. Subnormal EOG was not found in this group of patients. Detection of changes by EOG and in parallel small changes in ERG what was shown previously  indicating that the occurrence of abnormalities was mainly in the RPE.
The increased AI in NF-1 patients is a result of relatively low DTAs. The dark-trough potential is a result of polarisation differences between the apical and basal membranes of RPE cells . The significantly lower amplitude of this potential suggests that the mechanisms underlying polarization differences are altered in NF-1.
The apical membrane is more hyperpolarized than the basolateral membrane. This variation in membrane potentials results from differences in the types and distribution of transport mechanisms between the two RPE membranes. Primarily K+ channels generate the apical membrane potential with smaller contributions from the electrogenic Na+/K+ pump and Na+HCO3- cotransporter. The basolateral membrane potential is generated primarily by a balance between Cl- and K+ channels . The basolateral membrane Cl- conductance may be modulated by intracellular Ca2+ . It is reasonable to expect that changes in any of above transport mechanisms can occur in NF-1.
As mentioned in the introduction there are data indicating a correlation between the occurrence of neurofibromin and melanin abnormalities. Melanin has the capacity to bind and accumulate many chemicals . Pigmented cells contain particularly high amounts of calcium, reflecting the enormous calcium binding capacity of melanin . The data obtained in the current study suggest that supernormal EOGs in NF-1 patients are a result of changes in calcium levels caused by melanin abnormalities, which is related to the reduction in expression of neurofibromin.
This finding also supports the hypothesis that EOG changes in NF-1 patients are associated to neurofibromin-mediated melanin alterations.
It is well known that in many ocular disorders electrophysiological changes can occur independently of alterations detectable by ophthalmoscopy. Also in our patients abnormal EOGs were observed in individuals without characteristic NF-1 fundus changes detectable during routine examination.
NF-1 can be unequivocally diagnosed by the detection of NF-1 gene mutations by DNA/RNA analyses. Molecular analysis of large genes like NF-1 are still complex, time consuming and expensive. Due to cost implications genetic analysis of NF-1 has to be limited to the groups of pre-selected patients that have a high probability of carrying mutations. In order to identify such groups it is important to find as many independent clinical features as possible that are closely correlated with NF-1 disease expression.
The high frequency of supernormal EOGs in patients with NF-1 suggests that this type of analysis might be useful in the initial identification of patients with NF-1 who do not present with the typical spectrum of disease symptoms.
Korf BR: Ophthalmological issues in the neurofibromatoses. J Pediatr Ophthalmol Strabismus 1996, 33: 255–259.
Goldberg Y, Dibbern K, Klein J, Riccardi VM, Graham JM: Neurofibromatosis type I - an update and review for the primary pediatrician. Clinical Pediatrics 1996,35(11):545–561. 10.1177/000992289603501101
Gutmann DH, Collins FS: Neurofibromatosis type 1: beyond positional cloning. Arch Neurol 1993, 50: 1185–1193.
Gutmann DH, Collins FS: The neurofibromatosis type 1 gene and its product. Neurofibromin Neuron 1993, 10: 335–343. 10.1016/0896-6273(93)90324-K
Griesser J, Kaufmann D, Eisenbarth I, Bäuerle C, Krone W: Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1(NF1). Biol Chem Hoppe-Seyler 1995, 376: 91–101.
Kaufman D, Wiandt S, Veser J, Krone W: Increased melanogenesis in melanocytes from patients with neurofibromatosis 1. Hum Genet 1991, 87: 144–150. 10.1007/BF00204170
Jimbow K, Szabo G, Fitzpatrick TB: Ultrastructure of giant granules (macromelanosomes) in the cutaneous pigmented macules of neurofibromatosis. J Invest Dermatol 1973, 61: 300–309. 10.1111/1523-1747.ep12676518
Shields CL, Shields JA: Phakomatoses. Vitreoretinal Disease. The Essentials (Edited by: Regillo CD, Brown GC, Flynn HW). New York: Thieme 1999, 380–83.
Reeser F, Weinstein GW, Feiock KB, Oser RS: Electro-oculography as a test of retinal function. The normal and supernormal EOG. Am J Ophthalmol 1970, 4: 505–514.
Marmor MF, Zrenner E: Standard for clinicalelectro-oculography. Doc Ophthalmol 1993, 85: 115–124. 10.1007/BF01371127
Marmor MF: Standarization notice: EOG standard reapproved. Doc Ophthalmol 1998, 95: 91–92. 10.1023/A:1001788731171
Lubiński W, Zajączek S, Sych Z, Penkala K, Palacz O, Lubiński J: Electro-oculogram in patients with neurofibromatosis type 1. Doc Ophthalmol 2001, 103: 91–103. 10.1023/A:1012271206258
Gallemore RP, Maruiwa F, Marmor MF: Clinical electrophysiology of the retinal pigment epithelium. The Retinal Pigment Epithelium (Edited by: Marmor MF, Wolfensberger TJ). New York: Oxford University Press 1998, 200.
Ueda Y, Steinberg R: Chloride currents in freshly isolated rat retinal pigment epithelial cells. Exp Eye Res 1994, 58: 331–342. 10.1006/exer.1994.1023
Larsson BS: Interaction between chemicals and melanin. Pigment Cell Res 1993, 6: 127–133. 10.1111/j.1600-0749.1993.tb00591.x
Drager UC, Balkema GW: Does melanin do more than protect from light? Neurosci Res Suppl 1987, 6: S75-S86. 10.1016/0921-8696(87)90009-0
Schraermeyer U, Heimann K: Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Res 1999, 12: 225–226. 10.1111/j.1600-0749.1999.tb00755.x
The authors thank Ms Lila Rekowska for help with recordings and data acquisition.
About this article
Cite this article
Lubiński, W., Zajączek, S., Sych, Z. et al. Supernormal Electro-Oculograms in Patients with Neurofibromatosis Type 1. Hered Cancer Clin Pract 2, 193 (2004). https://doi.org/10.1186/1897-4287-2-4-193
- neurofibromatosis type 1
- retinal pigment epithelium